ImmunityBio, Inc. IBRX

Set alert

Price alert · IBRX

All alert types
7.95 USD -0.34 -4.10%

At close

7.92 -0.03 -0.38%

Pre-market · Nov 3, 8:02 AM ET

Bid
7.93 × 2
Ask
7.94 × 30
7.93 Day range 8.39
1.95 52-week range 12.43
YTD
+301.52%
1 year
+251.77%
Open
8.32
Prev close
8.29
Mkt cap
8.43B
Vol
9.05M
Avg vol
11.49M
EPS
-0.96
P/E
0.00
Div yield
0.00%
More statistics
Low
7.93
High
8.39
Forward P/E
-108.41
Beta
0.17
Short ratio
7.96
Inst. own
19.81%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
8.71
200-d avg
7.90
1y target
14.25

30m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (16)
NameTimeAgo
MACD: Sell SignalNov 2, 3:55 PM16 hours ago
MACD: Buy SignalNov 2, 2:55 PM17 hours ago
SMA: BearishNov 2, 9:55 AM22 hours ago
SMA: BullishOct 30, 3:55 PM3 days ago
SMA: BearishOct 30, 9:55 AM3 days ago
SMA: BearishOct 30, 9:55 AM3 days ago
SMA: BullishOct 29, 3:55 PM4 days ago
SMA: BullishOct 29, 3:25 PM4 days ago
SMA: BearishOct 29, 1:25 PM4 days ago
SMA: BearishOct 29, 12:55 PM4 days ago
RSI: OverboughtOct 29, 11:25 AM4 days ago
SMA: BullishOct 28, 3:55 PM5 days ago
RSI: OverboughtOct 28, 3:55 PM5 days ago
RSI: OverboughtOct 28, 2:25 PM5 days ago
SMA: BullishOct 28, 10:55 AM5 days ago
SMA: BearishOct 28, 10:25 AM5 days ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 14.25 +79.2% upside
Target (low)
12.00
Target (mean)
14.25
Target (high)
16.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IBRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.05-0.09 – 0.00-0.07+28.6%59.23M+84.7%3
Next quarter-0.04333-0.09 – 0.00-0.06+27.8%72.04M+88.2%3
Current year-0.915-0.93 – -0.90-0.38-140.8%226.56M+100.0%2
Next year-0.07333-0.32 – 0.10-0.915+92.0%471.90M+108.3%3

Upgrades and downgrades

The latest rating changes

IBRX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 15, 2026JefferiesMaintainedBuyBuy
Oct 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 21, 2026BTIGReiteratedBuyBuy
May 20, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 5, 2026D. Boral CapitalMaintainedBuyBuy
Apr 21, 2026D. Boral CapitalMaintainedBuyBuy
Apr 8, 2026D. Boral CapitalMaintainedBuyBuy
Mar 26, 2026D. Boral CapitalMaintainedBuyBuy
Mar 23, 2026D. Boral CapitalMaintainedBuyBuy
Mar 17, 2026D. Boral CapitalMaintainedBuyBuy
Mar 9, 2026D. Boral CapitalMaintainedBuyBuy
Mar 4, 2026Piper SandlerReiteratedOverweightOverweight
Feb 23, 2026D. Boral CapitalMaintainedBuyBuy
Feb 23, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 19, 2026D. Boral CapitalMaintainedBuyBuy
Feb 17, 2026D. Boral CapitalMaintainedBuyBuy
Jan 26, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 23, 2026D. Boral CapitalMaintainedBuyBuy
Jan 23, 2026BTIGMaintainedBuyBuy
Jan 20, 2026Piper SandlerMaintainedOverweightOverweight
Jan 20, 2026D. Boral CapitalMaintainedBuyBuy
Jan 16, 2026D. Boral CapitalMaintainedBuyBuy
Jan 13, 2026D. Boral CapitalMaintainedBuyBuy
Dec 16, 2025D. Boral CapitalMaintainedBuyBuy
Dec 12, 2025JefferiesMaintainedBuyBuy
Dec 12, 2025D. Boral CapitalMaintainedBuyBuy
Dec 11, 2025D. Boral CapitalMaintainedBuyBuy
Nov 13, 2025D. Boral CapitalMaintainedBuyBuy
Nov 5, 2025D. Boral CapitalMaintainedBuyBuy